Listing of Color Additives Exempt from Certification; Synthetic Iron Oxide

Size: px
Start display at page:

Download "Listing of Color Additives Exempt from Certification; Synthetic Iron Oxide"

Transcription

1 This document is scheduled to be published in the Federal Register on 03/20/2015 and available online at and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES P Food and Drug Administration 21 CFR Part 73 [Docket No. FDA-2013-C-1008] Listing of Color Additives Exempt from Certification; Synthetic Iron Oxide AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA or we) is amending the color additive regulations to provide for the expanded safe use of synthetic iron oxide as a color additive to include use in soft and hard candy, mints, and chewing gum. This action is in response to a petition filed by Wm. Wrigley Jr. Company (Wrigley). DATES: This rule is effective [INSERT DATE 30 DAYS PLUS 1 BUSINESS DAY AFTER DATE OF PUBLICATION IN THE FEDERAL REGISTER]. See section X for further information on the filing of objections. Submit either electronic or written objections and requests for a hearing by [INSERT DATE 30 DAYS AFTER DATE OF PUBLICATION IN THE FEDERAL REGISTER]. ADDRESSES: You may submit either electronic or written objections and requests for a hearing, identified by Docket No. FDA-2013-C-1008, by any of the following methods: Electronic Submissions Submit electronic objections in the following way:

2 2 Federal erulemaking Portal: Follow the instructions for submitting comments. Written Submissions Submit written objections in the following ways: Mail/Hand delivery/courier (for paper submissions): Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD Instructions: All submissions received must include the Docket No. FDA-2013-C-1008 for this rulemaking. All objections received will be posted without change to including any personal information provided. For detailed instructions on submitting objections, see the Objections heading of the SUPPLEMENTARY INFORMATION section. Docket: For access to the docket to read background documents or objections received, go to and insert the docket number, found in brackets in the heading of this document, into the Search box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, rm. 1061, Rockville, MD FOR FURTHER INFORMATION CONTACT: Laura A. Dye, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD , SUPPLEMENTARY INFORMATION: I. Introduction In a document published in the Federal Register of September 17, 2013 (78 FR 57105), we announced that we had filed a color additive petition (CAP 3C0298) submitted by Wm.

3 3 Wrigley Jr. Company, c/o Exponent Inc., 1150 Connecticut Ave. NW., Suite 1100, Washington DC (petitioner). The petition proposed to amend the color additive regulations in Synthetic Iron Oxide (21 CFR ) by expanding the safe use of synthetic iron oxide as a color additive to include use in soft and hard candy, mints, and chewing gum. The petitioner requested that the proposed uses be permitted at levels consistent with current good manufacturing practice (GMP). The petition also proposed to lower the specification limit for lead in synthetic iron oxide for human food use from 10 milligrams per kilogram (mg/kg; 10 parts per million (ppm)) to 5 mg/kg (5 ppm). II. Background Currently, synthetic iron oxides and their hydrated forms are approved as color additives for the following direct uses in human food, drugs, and cosmetics: (1) in sausage casings intended for consumption in an amount not exceeding 0.10 percent by weight of the finished food ( ); (2) in ingested or topically-applied drugs with a limit for ingested drugs of 5 milligrams, calculated as elemental iron, per day for labeled or prescribed dosages (21 CFR ); and (3) in cosmetics generally, including cosmetics applied to the area of the eye, in amounts consistent with GMP (21 CFR ). Synthetically prepared iron oxides and their hydrated forms include red iron oxide, yellow iron oxide, black iron oxide, and brown iron oxide, which is a blend of various iron oxides. For the subject petition, synthetic iron oxides are intended to be used in soft and hard candy, mints, and chewing gum in amounts consistent with GMP. The maximum GMP use level for iron oxides depends on the color of the iron oxide and the application. We have determined that the amount of the color additive used in these foods is self-limiting (Ref. 1). Therefore,

4 4 there is no need for a specific upper limit on the percent by weight of iron oxide in hard and soft candies, mints, and chewing gum in the regulation for these foods. III. Evaluation of Safety Under section 721(b)(4) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 379e(b)(4)), a color additive cannot be listed for a particular use unless the data and information available to FDA establishes that the color additive is safe for that use. FDA s color additive regulations in 21 CFR 70.3(i) define safe to mean that there is convincing evidence that establishes with reasonable certainty that no harm will result from the intended use of the color additive. To establish with reasonable certainty that a color additive intended for use in food is not harmful under its intended conditions of use, we consider the estimated human dietary exposure to the additive, the additive s toxicological data, and other relevant information (such as published literature) available to us. We compare an individual s estimated daily intake (EDI) of the additive from all sources to an acceptable daily intake (ADI) established by toxicological data. The EDI is determined by projections based on the amount of the additive proposed for use in particular foods and on data regarding the amount consumed from all sources of the additive. We typically use the EDI for the 90th percentile consumer of a color additive as a measure of high chronic dietary exposure. IV. Safety of Petitioned Use of the Additive To support the safety of the proposed uses of synthetic iron oxide, Wrigley provided information about iron intake expected to result from the proposed new uses of synthetic iron oxide, as well as intake from other sources of iron. There are many dietary sources of iron, including from food ingredients, dietary supplements, and from food that contains naturally

5 5 occurring iron. Specifically, Wrigley submitted detailed exposure estimates of iron that took into account the following: (1) The proposed uses of synthetic iron oxide as a color additive in soft and hard candy, mints, and chewing gum based on the maximum anticipated use levels; (2) the current use of synthetic iron oxide to color sausage casings; (3) background iron from conventional food based on the iron content declared on food labels; (4) iron from dietary supplements; and (5) oral exposure to iron oxides from their use as color additives in lipstick. These exposure estimates assumed that all of the iron that is present is absorbed in the gastrointestinal tract. Wrigley also provided exposure estimates to iron that took into account the bioavailability of iron from all current dietary sources, proposed uses, and lipstick. Wrigley compared these intake estimates to the Tolerable Upper Intake Level (UL) for iron established by the Institute of Medicine (IOM) of the National Academies. Based on this and other information, Wrigley concluded that the proposed use of synthetic iron oxide to color soft and hard candy, mints, and chewing gum is safe. A. Estimated Daily Intake of Iron Using food consumption data from the National Health and Nutrition Examination Survey (NHANES), Wrigley s estimated exposure to iron from the proposed uses in soft and hard candy, mints and chewing gum for the U.S. population (2 years of age and older) to be 16.3 mg/p/day (d) for the 90th percentile consumer. Wrigley also provided dietary exposure estimates to iron for children 2 to 5 years of age, children 2 to 13 years of age, and adolescents and adults 14 years of age and older. For these population groups, Wrigley estimated the exposure to iron from the proposed uses at the 90th percentile to be 12.2 mg/p/d, 15.6 mg/p/d, and 16.4 mg/p/d, respectively. Wrigley also estimated the cumulative exposure to iron from all food sources (current and proposed) for the U.S. population (2 years of age and

6 6 older) to be 40.6 mg/p/d for the 90th percentile consumer. Wrigley also provided dietary exposure estimates to iron for children 2 to 5 years of age, children 2 to 13 years of age, and adolescents and adults 14 years of age and older. For these population groups, Wrigley estimated the exposure to iron at the 90th percentile to be 31.2 mg/p/d, 34.6 mg/p/d, and 41.5 mg/p/d, respectively. In addition, Wrigley estimated exposure to iron from all food sources (current and proposed) and lipstick for females 10 to 13 years old, and 14 years of age and older. The exposure at the 90th percentile for these two population groups was 33.8 mg/p/d and 40.2 mg/p/d, respectively. Wrigley noted that these exposure estimates are conservative and assume that all of the iron present is bioavailable. We have no further questions regarding Wrigley s exposure estimates for iron in food and cosmetics and conclude that the petitioner s exposure estimates are sufficiently conservative to account for the use of iron oxides in ingested drugs (Ref. 2). We also conclude that exposure from indirect uses of iron oxides, such as for colorants for food-contact polymers authorized in 21 CFR , would not significantly contribute to the overall exposure to iron oxides. To address the bioavailability of iron, Wrigley provided information showing approximately 18 percent of iron from conventional foods and dietary supplements is bioavailable, and that about 1 percent of iron from synthetic iron oxide is bioavailable. Based on this information, Wrigley provided exposure estimates that take into account the bioavailability of iron. Wrigley estimated the exposure to bioavailable iron from the proposed uses at the 90th percentile to be 0.16 mg/p/d, 0.12 mg/p/d, 0.16 mg/p/d, and 0.16 mg/p/d for the U.S. population (2 years of age and older), children 2 to 5 years of age, children 2 to 13 years of age, and adolescents and adults 14 years of age and older, respectively. Wrigley estimated the cumulative exposure to bioavailable iron from all food sources (current and proposed) at the 90th percentile

7 7 to be 6.02 mg/p/d, 4.68 mg/p/d, 4.99 mg/p/d, and 6.21 mg/p/d for the U.S. population (2 years of age and older), children 2 to 5 years of age, children 2 to 13 years of age, and adolescents and adults 14 years of age and older, respectively. For females 10 to 13 years old, and 14 years of age and older, Wrigley estimated exposure to bioavailable iron from all food sources (current and proposed) and lipstick to be 5.07 mg/p/d and 6.12 mg/p/d, respectively (Ref. 2). B. Acceptable Intake Level for Iron In 2000, the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes of the Food and Nutrition Board at the IOM conducted an extensive review of relevant published scientific literature to determine dietary reference intakes and ULs for iron. The IOM published a detailed report that included a UL for iron of 40 mg/d for children (2 to 5 years of age and 2 to 13 years of age), and a UL of 45 mg/d for adolescents and adults (14 years of age and older) (Ref. 3). The IOM considers the UL as the highest daily intake level of a nutrient that poses no risk of adverse effects when the nutrient is consumed over long periods of time. The UL is determined using a risk assessment model developed specifically for nutrients and, generally speaking, may consider intake from such sources as food, water, nutrient supplements, and pharmacological agents. The dose-response assessment, which concludes with an estimate of the UL, is built upon three toxicological concepts commonly used in assessing the risk of exposures to chemical substances: No-observed-adverse-effect level, lowest-observed-effect level, and an uncertainty factor. We considered the ULs established by the IOM relative to the intake estimates as the primary basis for assessing the safety of iron from the proposed uses of synthetic iron oxide. We also reviewed scientific articles on the safety of iron submitted by Wrigley, as well as other relevant published studies available to FDA.

8 8 The exposure estimates to iron from all food sources, including the proposed use of synthetic iron oxide in soft and hard candy, mints, and chewing gum, at the 90th percentile for children 2 to 5 years of age and for children 2 to 13 years of age, without taking into account the bioavailability of the iron, is 31.2 mg/p/d and 34.6 mg/p/d, respectively. Both of these exposure estimates are below the UL for these age groups. The exposure estimate to iron from all food sources (current and proposed) and lipstick for females 10 to 13 years old at the 90th percentile of 33.8 mg/p/d is also below the UL established for this group. For adolescents and adults 14 years of age and older, the exposure estimate for iron at the 90th percentile of 41.5 mg/p/d is below the UL of 45 mg/p/d for adolescents 14 to 18 years of age. Similarly, the exposure estimate to iron from all food sources and lipstick for females 14 years of age and older of 40.2 mg/p/d at the 90th percentile is below the UL of 45 mg/p/d for adolescents and adults (14 years of age and older). Because the EDI of iron from all current and proposed food sources at the 90th percentile for each population group, which was estimated using conservative assumptions, is below the corresponding IOM UL for that population group, even without taking into account the low bioavailability of the iron from the petitioned uses, we conclude that there is a reasonable certainty of no harm from the proposed use of synthetic iron oxide as a color additive in soft and hard candy, mints, and chewing gum (Ref. 4). C. Lead Specification As discussed in section I, the petitioner proposed to lower the specification limit for lead in synthetic iron oxide for human food use in 21 CFR from 10 mg/kg to 5 mg/kg. To support the lower lead specification, the petitioner submitted data on lead levels from batch analyses of synthetic iron oxide. The data demonstrates that the proposed lead limit of 5 ppm is achievable with the use of good manufacturing practices in the production of the color additive

9 9 (Ref. 5). Because the lower specification limit is achievable, and also because the lower specification limit is consistent with the safe use of the color additive, we are lowering the lead specification limit for lead in synthetic iron oxide for human food as proposed. The lower specification applies to both the petitioned new use of synthetic iron oxide to color candy, chewing gum, and mints, as well as to the already-approved use of synthetic iron oxide for human food use in the coloring of sausage casings. V. Conclusion Based on the data and information in the petition and other relevant material, we conclude that the petitioned use of synthetic iron oxide in soft and hard candy, mints, and chewing gum is safe. We further conclude that the additive will achieve its intended technical effect and is suitable for the petitioned use. Consequently, we are amending the color additive regulations in 21 CFR part 73 as set forth in this document. In addition, based upon the factors listed in 21 CFR 71.20(b), we conclude that batch certification of synthetic iron oxide is not necessary for the protection of public health. VI. Public Disclosure In accordance with (21 CFR 71.15), the petition and the documents that we considered and relied upon in reaching our decision to approve the petition will be made available for public disclosure (see FOR FURTHER INFORMATION CONTACT). As provided in 71.15, we will delete from the documents any materials that are not available for public disclosure. VII. Environmental Impact We previously considered the environmental effects of this rule as stated in the September 17, 2013, notice of filing for CAP 3C0298 (78 FR 57105). We stated that we had

10 10 determined, under 21 CFR 25.32(k), that this action is of a type that does not individually or cumulatively have a significant effect on the human environment such that neither an environmental assessment nor an environmental impact statement is required. We have not received any new information or comments that would affect our previous determination. VIII. Paperwork Reduction Act of 1995 This final rule contains no collection of information. Therefore, clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 is not required. IX. Section 301(ll) of the FD&C Act Our review of this petition was limited to section 721 of the FD&C Act. This final rule is not a statement regarding compliance with other sections of the FD&C Act. For example, the Food and Drug Administration Amendments Act of 2007, which was signed into law on September 27, 2007, amended the FD&C Act to, among other things, add section 301(ll) of the FD&C Act (21 U.S.C. 331(ll)). Section 301(ll) of the FD&C Act prohibits the introduction or delivery for introduction into interstate commerce of any food that contains a drug approved under section 505 of the FD&C Act (21 U.S.C. 355), a biological product licensed under section 351 of the Public Health Service Act (42 U.S.C. 262), or a drug or biological product for which substantial clinical investigations have been instituted and their existence has been made public, unless one of the exemptions in section 301(ll)(1) to (ll)(4) of the FD&C Act applies. In our review of this petition, we did not consider whether section 301(ll) of the FD&C Act or any of its exemptions apply to food products containing this color additive. Accordingly, this final rule should not be construed to be a statement that a product containing this color additive, if introduced or delivered for introduction into interstate commerce, would not violate section 301(ll) of the FD&C Act. Furthermore, this language is included in all color additive final rules

11 11 that pertain to food and therefore should not be construed to be a statement of the likelihood that section 301(ll) of the FD&C Act applies. X. Objections This rule is effective as shown in the DATES section, except as to any provisions that may be stayed by the filing of proper objections. If you will be adversely affected by one or more provisions of this regulation, you may file with the Division of Dockets Management (see ADDRESSES) either electronic or written objections. You must separately number each objection, and within each numbered objection you must specify with particularity the provision to which you object and the grounds for your objection. Within each numbered objection, you must specifically state whether you are requesting a hearing on the particular provision that you specify in that numbered objection. If you do not request a hearing for any particular objection, you waive the right to a hearing on that objection. If you request a hearing, your objection must include a detailed description and analysis of the specific factual information you intend to present in support of the objection in the event that a hearing is held. If you do not include such a description and analysis for any particular objection, you waive the right to a hearing on the objection. It is only necessary to send one set of documents. Identify documents with the docket number found in brackets in the heading of this document. Any objections received in response to the regulation may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at We will publish notice of the objections that we have received or lack thereof in the Federal Register. XI. References

12 12 The following references have been placed on display in the Division of Dockets Management (see ADDRESSES) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday, and are available electronically at (FDA has verified the Web site addresses in this reference section, but FDA is not responsible for any subsequent changes to Web sites after this document publishes in the Federal Register.) 1. Memorandum to the File from A. Zajac, Division of Petition Review, February 27, Memorandum from D. Doell, Chemistry Review Group, Division of Petition Review, to L. Dye, Regulatory Group II, Division of Petition Review, June 20, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press, Memorandum from S. Thurmond, Toxicology Team, Division of Petition Review, to L. Dye, Regulatory Group II, Division of Petition Review, September 9, Memorandum from N. Hepp, Color Technology Team, Office of Cosmetics and Colors, to L. Dye, Division of Petition Review, September 23, List of Subjects in 21 CFR Part 73 Color additives, Cosmetics, Drugs, and Medical devices. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, and redelegated to the Director, Center for Food Safety and Applied Nutrition, 21 CFR part 73 is amended as follows: PART 73--LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION 1. The authority citation for 21 CFR part 73 continues to read as follows:

13 13 Authority: 21 U.S.C. 321, 341, 342, 343, 348, 351, 352, 355, 361, 362, 371, 379e. 2. Section is amended by revising paragraphs (b)(1) and (c)(1) to read as follows: Synthetic iron oxide. * * * * * (b) * * * (1) Synthetic iron oxide for human food use shall conform to the following specifications: Arsenic (as As), not more than 3 milligrams per kilogram (mg/kg) (3 parts per million (ppm)). Lead (as Pb), not more than 5 mg/kg (5 ppm). Mercury (as Hg), not more than 1 mg/kg (1 ppm). * * * * * (c) * * * (1) Synthetic iron oxide may be safely used for human food use subject to the following restrictions: (i) In sausage casings intended for human consumption in an amount not exceeding 0.10 percent by weight of the finished food. (ii) In soft and hard candy, mints, and chewing gum at levels consistent with good manufacturing practice, except that it may not be used to color foods for which standards of identity have been issued under section 401 of the Federal Food, Drug, and Cosmetic Act, unless the use of the added color is authorized by such standards. * * * * *

14 14 Dated: March 17, Susan M. Bernard, Director, Office of Regulations, Policy and Social Sciences, Center for Food Safety and Applied Nutrition. [FR Doc Filed: 3/19/ :45 am; Publication Date: 3/20/2015]

SUMMARY: The Food and Drug Administration (FDA or we) is amending the color additive

SUMMARY: The Food and Drug Administration (FDA or we) is amending the color additive This document is scheduled to be published in the Federal Register on 08/21/2015 and available online at http://federalregister.gov/a/2015-20676, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

DATES: This rule is effective December 8, See section X for further information on the

DATES: This rule is effective December 8, See section X for further information on the This document is scheduled to be published in the Federal Register on 11/07/2017 and available online at https://federalregister.gov/d/2017-24194, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Food Additives Permitted for Direct Addition to Food for Human Consumption; Acacia (Gum

Food Additives Permitted for Direct Addition to Food for Human Consumption; Acacia (Gum This document is scheduled to be published in the Federal Register on 12/06/2013 and available online at http://federalregister.gov/a/2013-29073, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Listing of Color Additives Exempt From Certification; Spirulina Extract

Listing of Color Additives Exempt From Certification; Spirulina Extract This document is scheduled to be published in the Federal Register on 08/13/2013 and available online at http://federalregister.gov/a/2013-19550, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Indirect Food Additives: Adhesives and Components of Coatings and Paper and Paperboard Components

Indirect Food Additives: Adhesives and Components of Coatings and Paper and Paperboard Components 4 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 175 and 176 [Docket No. 99F-09253 Indirect Food Additives: Adhesives and Components of Coatings and Paper and Paperboard

More information

Food Labeling: Revision of the Nutrition and Supplement Facts Labels and Serving Sizes of

Food Labeling: Revision of the Nutrition and Supplement Facts Labels and Serving Sizes of This document is scheduled to be published in the Federal Register on 10/02/2017 and available online at https://federalregister.gov/d/2017-21019, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Agency Information Collection Activities; Submission for Office of Management and

Agency Information Collection Activities; Submission for Office of Management and This document is scheduled to be published in the Federal Register on 02/19/2019 and available online at https://federalregister.gov/d/2019-02596, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Flavored Milk; Petition to Amend the Standard of Identity for Milk and 17 Additional Dairy

Flavored Milk; Petition to Amend the Standard of Identity for Milk and 17 Additional Dairy This document is scheduled to be published in the Federal Register on 02/20/2013 and available online at http://federalregister.gov/a/2013-03835, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D 2

Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D 2 This document is scheduled to be published in the Federal Register on 03/11/2014 and available online at http://federalregister.gov/a/2014-05060, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

ACTION: Notification; declaratory order; extension of compliance date.

ACTION: Notification; declaratory order; extension of compliance date. This document is scheduled to be published in the Federal Register on 05/21/2018 and available online at https://federalregister.gov/d/2018-10714, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES

More information

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated This document is scheduled to be published in the Federal Register on 11/22/2017 and available online at https://federalregister.gov/d/2017-25245, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Highly Concentrated Caffeine in Dietary Supplements; Guidance for Industry; Availability

Highly Concentrated Caffeine in Dietary Supplements; Guidance for Industry; Availability This document is scheduled to be published in the Federal Register on 04/16/2018 and available online at https://federalregister.gov/d/2018-07836, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the This document is scheduled to be published in the Federal Register on 05/15/2017 and available online at https://federalregister.gov/d/2017-09754, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Agency Information Collection Activities; Submission for Office of Management and Budget

Agency Information Collection Activities; Submission for Office of Management and Budget This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is proposing to

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is proposing to This document is scheduled to be published in the Federal Register on 10/26/2016 and available online at https://federalregister.gov/d/2016-25850, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is amending its

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is amending its This document is scheduled to be published in the Federal Register on 10/26/2016 and available online at https://federalregister.gov/d/2016-25851, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for

Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for This document is scheduled to be published in the Federal Register on 12/14/2018 and available online at https://federalregister.gov/d/2018-27098, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Safety Evaluation for Substances Directly Added to Food

Safety Evaluation for Substances Directly Added to Food Safety Evaluation for Substances Directly Added to Food Teresa Croce, PhD Office of Food Additive Safety Center for Food Safety and Applied Nutrition US Food and Drug Administration How Does FDA Regulate

More information

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for This document is scheduled to be published in the Federal Register on 12/13/2017 and available online at https://federalregister.gov/d/2017-26785, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Food Labeling: Health Claims; Dietary Saturated Fat and Cholesterol and Risk of Coronary

Food Labeling: Health Claims; Dietary Saturated Fat and Cholesterol and Risk of Coronary This document is scheduled to be published in the Federal Register on 12/19/2016 and available online at https://federalregister.gov/d/2016-29997, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Agency Information Collection Activities; Submission for Office of Management and

Agency Information Collection Activities; Submission for Office of Management and This document is scheduled to be published in the Federal Register on 03/04/2019 and available online at https://federalregister.gov/d/2019-03824, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Food Labeling: Revision of the Nutrition and Supplement Facts Labels; Supplemental Proposed

Food Labeling: Revision of the Nutrition and Supplement Facts Labels; Supplemental Proposed This document is scheduled to be published in the Federal Register on 07/27/2015 and available online at http://federalregister.gov/a/2015-17928, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Infant Formula: The Addition of Minimum and Maximum Levels of Selenium to Infant Formula

Infant Formula: The Addition of Minimum and Maximum Levels of Selenium to Infant Formula This document is scheduled to be published in the Federal Register on 04/16/2013 and available online at http://federalregister.gov/a/2013-08855, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Food Labeling: Revision of the Nutrition and Supplement Facts Labels

Food Labeling: Revision of the Nutrition and Supplement Facts Labels This document is scheduled to be published in the Federal Register on 03/03/2014 and available online at http://federalregister.gov/a/2014-04387, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015 DEPARTMENT OF HEALTH & HUMAN SERVICES Silver Spring, MD 20993 ANDA 060851 Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY 10970 Docket No. FDA-2011-P-0081

More information

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing;

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing; 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 15 [Docket No. FDA-2013-N-0402] Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public

More information

National Organic Program (NOP); Sunset 2017 Amendments to the National List

National Organic Program (NOP); Sunset 2017 Amendments to the National List This document is scheduled to be published in the Federal Register on 07/06/2017 and available online at https://federalregister.gov/d/2017-14006, and on FDsys.gov DEPARTMENT OF AGRICULTURE Agricultural

More information

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: The Department of Veterans Affairs (VA) proposes to amend its medical

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: The Department of Veterans Affairs (VA) proposes to amend its medical This document is scheduled to be published in the Federal Register on 08/05/2016 and available online at http://federalregister.gov/a/2016-18660, and on FDsys.gov DEPARTMENT OF VETERANS AFFAIRS 8320-01

More information

Summary p. 1 What Are Dietary Reference Intakes? p. 2 Approach for Setting Dietary Reference Intakes p. 7 Nutrient Functions and the Indicators Used

Summary p. 1 What Are Dietary Reference Intakes? p. 2 Approach for Setting Dietary Reference Intakes p. 7 Nutrient Functions and the Indicators Used Summary p. 1 What Are Dietary Reference Intakes? p. 2 Approach for Setting Dietary Reference Intakes p. 7 Nutrient Functions and the Indicators Used to Estimate Requirements p. 10 Criteria and Proposed

More information

Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl. AGENCY: Drug Enforcement Administration, Department of Justice

Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl. AGENCY: Drug Enforcement Administration, Department of Justice This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23183, and on FDsys.gov Billing Code 4410-09-P DEPARTMENT OF

More information

FDA s Food Additives Program

FDA s Food Additives Program FDA s Food Additives Program LaShonda T. Cureton, PhD Office of Food Additive Safety US Food and Drug Administration Food Additives: A Global Perspective on Safety Evaluation and Use Procedures for Approval

More information

Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders; AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders; AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. This document is scheduled to be published in the Federal Register on 02/29/2012 and available online at http://federalregister.gov/a/2012-04869, and on FDsys.gov DEPARTMENT OF TRANSPORTATION Federal Motor

More information

Patient-Focused Drug Development Public Meeting on Chagas Disease

Patient-Focused Drug Development Public Meeting on Chagas Disease This document is scheduled to be published in the Federal Register on 12/10/2014 and available online at http://federalregister.gov/a/2014-28828, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Food Additives Program

Food Additives Program U.S. FDA s Food Additive Program: An Update on Resources and Challenges 18 th Food Packaging Law Seminar October 11, 2017 Arlington, VA 1 Food Additives Program Dennis Keefe, PhD Director, Office of Food

More information

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory This document is scheduled to be published in the Federal Register on 03/01/2018 and available online at https://federalregister.gov/d/2018-04167, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

The Food and Drug Administration's Approach to Evaluating Nicotine Replacement Therapies;

The Food and Drug Administration's Approach to Evaluating Nicotine Replacement Therapies; This document is scheduled to be published in the Federal Register on 11/30/2017 and available online at https://federalregister.gov/d/2017-25671, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Notice of Request for Extension of Approval of an Information Collection; Swine Health. AGENCY: Animal and Plant Health Inspection Service, USDA.

Notice of Request for Extension of Approval of an Information Collection; Swine Health. AGENCY: Animal and Plant Health Inspection Service, USDA. This document is scheduled to be published in the Federal Register on 09/24/2013 and available online at http://federalregister.gov/a/2013-23194, and on FDsys.gov DEPARTMENT OF AGRICULTURE Animal and Plant

More information

Dietary Supplement Health and Education Act of 1994 Public Law rd Congress

Dietary Supplement Health and Education Act of 1994 Public Law rd Congress Dietary Supplement Health and Education Act of 1994 Public Law 103-417 103rd Congress An Act To amend the Federal Food, Drug, and Cosmetic Act to establish standards with respect to dietary supplements,

More information

May 7, Dear Mr. Landa:

May 7, Dear Mr. Landa: Ralph A. Simmons 202 429 6459 rsimmons@steptoe.com 1330 Connecticut Avenue, NW Washington, DC 20036-1795 202 429 3000 main www.steptoe.com May 7, 2013 Michael M. Landa Director, Center for Food Safety

More information

Fruit Juice and Vegetable Juice as Color Additives in Food: Guidance for Industry

Fruit Juice and Vegetable Juice as Color Additives in Food: Guidance for Industry Fruit Juice and Vegetable Juice as Color Additives in Food: Guidance for Industry Draft Guidance This guidance is being distributed for comment purposes only. Although you can comment on any guidance at

More information

Using new scientific knowledge to update regulations in the U.S.

Using new scientific knowledge to update regulations in the U.S. Using new scientific knowledge to update regulations in the U.S. Maricel Maffini, Ph.D. Food Packaging Forum 5 October, 2017 US Food Additives Regulatory Program Administered by the Food and Drug Administration

More information

DEPARTMENT OF TRANSPORTATION. National Highway Traffic Safety Administration. [Docket Number: NHTSA ]

DEPARTMENT OF TRANSPORTATION. National Highway Traffic Safety Administration. [Docket Number: NHTSA ] This document is scheduled to be published in the Federal Register on 10/04/2018 and available online at https://federalregister.gov/d/2018-21623, and on govinfo.gov DEPARTMENT OF TRANSPORTATION National

More information

National Vaccine Injury Compensation Program: Adding the Category of Vaccines. AGENCY: Health Resources and Services Administration (HRSA), HHS.

National Vaccine Injury Compensation Program: Adding the Category of Vaccines. AGENCY: Health Resources and Services Administration (HRSA), HHS. This document is scheduled to be published in the Federal Register on 04/04/2018 and available online at https://federalregister.gov/d/2018-06770, and on FDsys.gov Billing Code: 4165-15 DEPARTMENT OF HEALTH

More information

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments

More information

TOBACCO PRODUCT OR MEDICAL PRODUCT?

TOBACCO PRODUCT OR MEDICAL PRODUCT? TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:

More information

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: The Department of Veterans Affairs (VA) is amending its medical

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: The Department of Veterans Affairs (VA) is amending its medical This document is scheduled to be published in the Federal Register on 03/23/2017 and available online at https://federalregister.gov/d/2017-05799, and on FDsys.gov DEPARTMENT OF VETERANS AFFAIRS 8320-01

More information

Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices; Public

Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices; Public This document is scheduled to be published in the Federal Register on 07/11/2016 and available online at http://federalregister.gov/a/2016-16353, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for. Over-the-Counter Human Use; Amendment of Monograph for OTC Nasal

Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for. Over-the-Counter Human Use; Amendment of Monograph for OTC Nasal 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 341 [Docket No. 1976N 0052N] (formerly 76N 052N) RIN 0910 AF34 Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic

More information

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance

More information

<AGENCY TYPE='S'>DEPARTMENT OF HEALTH AND HUMAN SERVICES. <SUBJECT>New Animal Drugs; Hyaluronate Sodium; Hydrogen Peroxide; Imidacloprid and

<AGENCY TYPE='S'>DEPARTMENT OF HEALTH AND HUMAN SERVICES. <SUBJECT>New Animal Drugs; Hyaluronate Sodium; Hydrogen Peroxide; Imidacloprid and This document is scheduled to be published in the Federal Register on 12/09/2013 and available online at http://federalregister.gov/a/2013-29234, and on FDsys.gov DEPARTMENT

More information

C~ 6 D~~J ~ old ~ s rw~ o, - _ - 2 DEPARTMENT OF HEALTH AND HUMAN SERVICES. Food and Drug Administration. 21 CFR Part 530

C~ 6 D~~J ~ old ~ s rw~ o, - _ - 2 DEPARTMENT OF HEALTH AND HUMAN SERVICES. Food and Drug Administration. 21 CFR Part 530 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 530, s rw~ o, - _ - 2 [Docket No. 2006N-0106] New Animal Drugs ; Adamantane and Neuraminidase Inhibitor Anti-influenza Drugs

More information

Centers for Disease Control and Prevention. CDC Sex-Specific Body Mass Index (BMI)-For-Age Growth Charts

Centers for Disease Control and Prevention. CDC Sex-Specific Body Mass Index (BMI)-For-Age Growth Charts This document is scheduled to be published in the Federal Register on 01/08/2018 and available online at https://federalregister.gov/d/2018-00060, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF

More information

Availability of FSIS Compliance Guidelines for Allergens and. Ingredients of Public Health Concern: Identification, Prevention

Availability of FSIS Compliance Guidelines for Allergens and. Ingredients of Public Health Concern: Identification, Prevention This document is scheduled to be published in the Federal Register on 11/16/2015 and available online at http://federalregister.gov/a/2015-28935, and on FDsys.gov Billing Code 3410-DM-P DEPARTMENT OF AGRICULTURE

More information

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Document issued on: November 12, 2002 This document supersedes the

More information

Modifications to Labeling of Nicotine Replacement Therapy Products for Over-the-Counter

Modifications to Labeling of Nicotine Replacement Therapy Products for Over-the-Counter This document is scheduled to be published in the Federal Register on 04/02/2013 and available online at http://federalregister.gov/a/2013-07528, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Guidance for Industry and FDA Staff

Guidance for Industry and FDA Staff Guidance for Industry and FDA Staff Whole Grain Label Statements Draft Guidance This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document

More information

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and This document is scheduled to be published in the Federal Register on 11/29/2018 and available online at https://federalregister.gov/d/2018-26045, and on govinfo.gov Billing Code 4410-09-P DEPARTMENT OF

More information

Product Stewardship Information Sheet CH350LN

Product Stewardship Information Sheet CH350LN Product Stewardship Information Sheet CH350LN Contents Product Manufacturer... 2 Food Contact... 2 European Union (EU) Food Contact... 2 US Food and Drug Administration (FDA)... 2 Canada Health Protection

More information

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Food Ingredients Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Disclosures Think Healthy Group, Inc. George Mason University, Department of Nutrition and Food Studies Journal of the American College

More information

DEPARTMENT OF VETERANS AFFAIRS Secondary Service Connection for Diagnosable Illnesses Associated With Traumatic

DEPARTMENT OF VETERANS AFFAIRS Secondary Service Connection for Diagnosable Illnesses Associated With Traumatic This document is scheduled to be published in the Federal Register on 12/10/2012 and available online at http://federalregister.gov/a/2012-29709, and on FDsys.gov DEPARTMENT OF VETERANS AFFAIRS 8320-01

More information

Centers for Disease Control and Prevention. Recommendations for Providers Counseling Male Patients and

Centers for Disease Control and Prevention. Recommendations for Providers Counseling Male Patients and This document is scheduled to be published in the Federal Register on 12/02/2014 and available online at http://federalregister.gov/a/2014-27814, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF

More information

Product Stewardship Information Sheet CH200LN-02

Product Stewardship Information Sheet CH200LN-02 Product Stewardship Information Sheet CH200LN-02 Contents Product Manufacturer... 2 Food Contact... 2 European Union (EU) Food Contact... 2 US Food and Drug Administration (FDA)... 2 Canada Health Protection

More information

Pipeline and Hazardous Materials Safety Administration. Hazardous Materials: Carriage of Battery-Powered Electronic Smoking Devices in

Pipeline and Hazardous Materials Safety Administration. Hazardous Materials: Carriage of Battery-Powered Electronic Smoking Devices in This document is scheduled to be published in the Federal Register on 05/19/2016 and available online at http://federalregister.gov/a/2016-11729, and on FDsys.gov Billing Code: 4910-60-P DEPARTMENT OF

More information

COMMISSION DELEGATED REGULATION (EU).../... of XXX

COMMISSION DELEGATED REGULATION (EU).../... of XXX EUROPEAN COMMISSION Brussels, XXX SANTE/10355/2015 (POOL/E4/2015/10355/10355-EN. doc) [...1(2015) XXX draft COMMISSION DELEGATED REGULATION (EU).../... of XXX supplementmg Regulation (EU) No 609/2013 of

More information

Use of Standards in Substantial Equivalence Determinations

Use of Standards in Substantial Equivalence Determinations Guidance for Industry and for FDA Staff Use of Standards in Substantial Equivalence Determinations Document issued on: March 12, 2000 U.S. Department Of Health And Human Services Food and Drug Administration

More information

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC), This document is scheduled to be published in the Federal Register on 09/26/2017 and available online at https://federalregister.gov/d/2017-20511, and on FDsys.gov BILLING CODE 4163-18-P DEPARTMENT OF

More information

New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of

New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of This document is scheduled to be published in the Federal Register on 06/08/2016 and available online at http://federalregister.gov/a/2016-13517, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

International Food Systems QUALITY SERVICE INNOVATION IN FOOD INGREDIENTS

International Food Systems QUALITY SERVICE INNOVATION IN FOOD INGREDIENTS Product Specification Sheet Organic Sprouted Purple Corn Blend W/ Sprouted Grains Product No: QH 24-3 Description: Organic Sprouted Purple Corn Blend QH 24-3 is a dark colored grain blend intended for

More information

Overview of Regulatory Science of Food Contact Substances

Overview of Regulatory Science of Food Contact Substances Overview of Regulatory Science of Food Contact Substances Michael A. Adams, PhD Deputy Director, Office of Food Additive Safety FDA, Center for Food Safety and Applied Nutrition 5001 Campus Drive, College

More information

The Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications

The Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications The Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications RadTech UV & EB Technology Expo & Conference 2012 Presented by David J. Ettinger Partner Keller and Heckman LLP

More information

Use of Light, Mild, Low, or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products

Use of Light, Mild, Low, or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products Guidance for Industry and FDA Staff Use of Light, Mild, Low, or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products June 2010 For questions regarding this guidance, contact the

More information

51ST LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 2013

51ST LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 2013 SENATE BILL ST LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 0 INTRODUCED BY Peter Wirth 0 AN ACT RELATING TO COMMERCE; AMENDING AND ENACTING SECTIONS OF THE NEW MEXICO FOOD ACT AND THE COMMERCIAL

More information

Department of Health and Human Services. Part II

Department of Health and Human Services. Part II Vol. 81 Friday, No. 103 May 27, 2016 Part II Department of Health and Human Services Food and Drug Administration 21 CFR Part 101 Food Labeling: Revision of the Nutrition and Supplement Facts Labels; Serving

More information

Purpose of this Document

Purpose of this Document Guidance on the Procedures for Joint Food Safety and Inspection Service (FSIS) and Food and Drug Administration (FDA) Approval of Ingredients and Sources of Radiation Used in the Production of Meat and

More information

SENATE BILL No Introduced by Senator Wieckowski. February 16, 2017

SENATE BILL No Introduced by Senator Wieckowski. February 16, 2017 SENATE BILL No. 504 Introduced by Senator Wieckowski February 16, 2017 An act to add Article 8.5 (commencing with Section 110961) to Chapter 5 of Part 5 of Division 104 of the Health and Safety Code, relating

More information

Establishment of a New Drug Code for Marihuana Extract. AGENCY: Drug Enforcement Administration, Department of Justice.

Establishment of a New Drug Code for Marihuana Extract. AGENCY: Drug Enforcement Administration, Department of Justice. This document is scheduled to be published in the Federal Register on 12/14/2016 and available online at https://federalregister.gov/d/2016-29941, and on FDsys.gov Billing Code 4410-09-P DEPARTMENT OF

More information

GENERAL PRINCIPLES FOR ESTABLISHING

GENERAL PRINCIPLES FOR ESTABLISHING Association of South East Asian Nations (ASEAN) GENERAL PRINCIPLES FOR ESTABLISHING MAXIMUM LEVELS OF VITAMINS AND MINERALS IN HEALTH SUPPLEMENTS Version 4.0 DOCUMENT INFORMATION This version was adopted

More information

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Reprinted from FDA s website by EAS Consulting Group, LLC Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed

More information

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC), This document is scheduled to be published in the Federal Register on 06/01/2018 and available online at https://federalregister.gov/d/2018-11789, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF

More information

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION Citizen Petition to: Margaret A. Hamburg, M.D, Commissioner of Food and Drugs Docket No. For Review of Standard of Identity

More information

Guidance for Industry

Guidance for Industry Reprinted from FDA s website by Guidance for Industry Bar Code Label Requirements Questions and Answers (Question 12 Update) DRAFT GUIDANCE This guidance document is for comment purposes only. Submit comments

More information

SUMMARY: Before a Federal agency can collect certain information from the public, it must

SUMMARY: Before a Federal agency can collect certain information from the public, it must This document is scheduled to be published in the Federal Register on 08/08/2017 and available online at https://federalregister.gov/d/2017-16651, and on FDsys.gov 4910-59-P DEPARTMENT OF TRANSPORTATION

More information

Health Canada s Safety Assessment Process for Sugar Substitutes

Health Canada s Safety Assessment Process for Sugar Substitutes Health Canada s Safety Assessment Process for Sugar Substitutes Janice Weightman Bureau of Chemical Safety Food Directorate, Health Canada April 24, 2014 Overview Canadians generally have a taste for sweet

More information

Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR

Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR This document is scheduled to be published in the Federal Register on 10/18/2016 and available online at https://federalregister.gov/d/2016-25144, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF

More information

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by

More information

Today is the Day - Final Regulations on Nutrition and Supplement Facts Labels and Serving Sizes Officially Published in the Federal Register

Today is the Day - Final Regulations on Nutrition and Supplement Facts Labels and Serving Sizes Officially Published in the Federal Register Today is the Day - Final Regulations on Nutrition and Supplement Facts Labels and Serving Sizes Officially Published in the Federal Register By: Carolina M. Wirth and Alyson L. Wooten PharmD Today, Friday,

More information

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below. ADVISORY Food & Drug FDA ISSUES PROPOSED RULE TO ESTABLISH A UNIQUE DEVICE IDENTIFICATION SYSTEM FOR MEDICAL DEVICES July 16, 2012 On July 11, 2012, the Food and Drug Administration (FDA) published in

More information

Schedules of Controlled Substances: Placement in Schedule V of Certain FDA- Approved Drugs Containing Cannabidiol; Corresponding Change to Permit

Schedules of Controlled Substances: Placement in Schedule V of Certain FDA- Approved Drugs Containing Cannabidiol; Corresponding Change to Permit This document is scheduled to be published in the Federal Register on 09/28/2018 and available online at https://federalregister.gov/d/2018-21121, and on govinfo.gov Billing Code 4410-09-P DEPARTMENT OF

More information

Food Irradiation: FDA s Perspective Teresa Croce, Ph.D.

Food Irradiation: FDA s Perspective Teresa Croce, Ph.D. Food Irradiation: FDA s Perspective Teresa Croce, Ph.D. Office of Food Additive Safety Center for Food Safety and Applied Nutrition US Food and Drug Administration March 25, 2015 Federal Food, Drug, &

More information

2014 FDA/JIFSAN Food & Nutrition Webinar

2014 FDA/JIFSAN Food & Nutrition Webinar 2014 FDA/JIFSAN Food & Nutrition Webinar Medical Foods Shawne Suggs-Anderson, MMSc, _ RD Infant Formula and Medical Foods Staff ONLDS/CFSAN/FDA September 23, 2014 53 Main Objectives History What is a Medical

More information

COPPER. Proper name(s): Copper (Sweetman 2007; O Neil et al. 2001) Common name(s): Copper (Sweetman 2007; O Neil et al. 2001)

COPPER. Proper name(s): Copper (Sweetman 2007; O Neil et al. 2001) Common name(s): Copper (Sweetman 2007; O Neil et al. 2001) COPPER Date: November 8, 2007 Proper name(s): Copper (Sweetman 2007; O Neil et al. 2001) Common name(s): Copper (Sweetman 2007; O Neil et al. 2001) Source material(s): < Calcium copper edetate (Sweetman

More information

Draft Guidance for Industry and FDA Staff

Draft Guidance for Industry and FDA Staff Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document

More information

A. Concentrated Omega-3 Dietary Supplements Provide Recognized Health Benefits

A. Concentrated Omega-3 Dietary Supplements Provide Recognized Health Benefits DEANNA TANNER OKUN Tel: (202) 407-8615 okun@adduci.com VIA ELECTRONIC FILING AND OVERNIGHT MAIL The Honorable Lisa R. Barton Secretary to the Commission United States International Trade Commission 500

More information

February 10, Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

February 10, Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 February 10, 2014 Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. FDA-2013-N-1317 Dear Sir or Madam: The American Heart

More information